耳科生物标志物鉴别梅尼埃病与前庭性偏头痛
本研究为横断面队列研究,纳入19例梅尼埃病(MD)和11例前庭性偏头痛(VM)患者,评估prestin和otolin-1作为鉴别生物标志物的作用。MD组prestin均值2.33 ng/ml,VM组0.64 ng/ml(p=0.238);MD组otolin-1为109.67 pg/ml,VM组30.9 pg/ml(p=0.102)。MD患者中prestin水平与言语识别率相关,尤其当prestin>2 ng/ml时相关性最强(rho=0.9;p=0.019)。结论认为两种标志物在两组间有差异,但鉴别作用尚待阐明。
要点
- MD与VM患者prestin和otolin-1水平有差异,但组间比较未达统计学显著。
- MD患者中prestin水平与言语识别率相关,提示其可能反映内耳功能。
- prestin和otolin-1用于鉴别MD与VM的价值仍需进一步研究。
核心结论
- Prestin和otolin-1水平在MD与VM患者间存在差异,但鉴别两种疾病的作用尚未明确。
研究设计与样本
- 横断面队列研究,纳入19例梅尼埃病患者和11例前庭性偏头痛患者。
主要发现
- MD组prestin平均2.33 ng/ml,VM组0.64 ng/ml(p=0.238)。
- MD组otolin-1平均109.67 pg/ml,VM组30.9 pg/ml(p=0.102)。
- MD患者中prestin水平与言语识别率相关,prestin>2 ng/ml时相关性最强(rho=0.9;p=0.019)。
临床怎么用
- prestin可能作为反映MD患者内耳功能的标志物,但不足以单独鉴别MD与VM。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the role for prestin and otolin-1 as biomarkers for differentiating Meniere's disease (MD) from vestibular migraine (VM). STUDY DESIGN: It is a cross-sectional, cohort study. RESULTS: There were 19 MD and 11 VM patients. In the 19 MD patients, the mean prestin level was 2.33 ng/ml compared to 0.64 ng/ml in VM patients (p = 0.238). Otolin-1 levels in MD patients were 109.67 pg/ml, while in VM patients, otolin-1 levels were 30.9 pg/ml (p = 0.102). In MD patients, prestin levels were correlated with word recognition scores, being strongest when prestin >2 ng/ml (rho = 0.9; p = 0.019). CONCLUSIONS: Prestin and otolin-1 levels differed between MD patients relative to VM patients. The relationship between prestin and word recognition scores in MD suggests that there may be a role for prestin as a marker for inner ear function, but its role in differentiating MD from VM remains to be elucidated.
引用
- Naples JG, Soda D, Rahman K, et al. Evaluating the Role of Otologic Biomarkers to Differentiate Meniere's Disease and Vestibular Migraine. Ear Hear. 2022. PMID: 34495899. doi:10.1097/AUD.0000000000001123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。